⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NXL News
Nexalin Technology, Inc. Common Stock
RedChip's Biotech Investor Conference Replays Now Available
accessnewswire.com
SXTP
BIVI
BFRG
LTRN
NXL
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
globenewswire.com
NXLIW
NXL
Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
globenewswire.com
NXLIW
NXL
Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
globenewswire.com
NXL
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
accessnewswire.com
SXTP
BIVI
BFRG
LTRN
NXL
Form 8-K
sec.gov
NXL
Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
globenewswire.com
NXLIW
NXL
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders
globenewswire.com
NXLIW
NXL
Nexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
accessnewswire.com
NXL
Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
globenewswire.com
NXLIW
NXL